Tomoyuki Odani

Title: Tomoyuki Odani: Innovator in Immunology

Introduction

Tomoyuki Odani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 4 patents, Odani's work focuses on the development of immunosuppressant receptors and their potential applications in treating various diseases.

Latest Patents

One of Odani's latest patents involves the use of an antagonist of BIR1 (B cell immunoglobulin receptor 1). This invention relates to a method for screening the antagonist, as well as subtype polypeptides of BIR1, the polynucleotide encoding them, and antibodies for the polypeptides. BIR1 functions as an immunosuppressive receptor, and the antagonist of BIR1 exhibits immunopotentive activity. This innovation has the potential to be used for preventing and/or treating cancer, immunodeficiency diseases, or infectious diseases.

Career Highlights

Odani is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding of immunological responses and therapeutic interventions.

Collaborations

Throughout his career, Odani has collaborated with notable colleagues, including Hideaki Tada and Kimiho Yamada. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Tomoyuki Odani's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also holds promise for future medical applications.